Walmart Inc. (NYSE: WMT) agreed on Friday to pay $50 million to settle a Department of Justice lawsuit alleging its pharmacies unlawfully filled opioid prescriptions.

The retailer admitted no wrongdoing and described the payout as "immaterial" in a regulatory filing. The settlement resolves allegations that Walmart violated the Controlled Substances Act since 2013 by ignoring red flags on suspicious prescriptions.

Settlement Context

The $50 million sum is a fraction of the billions in civil penalties Walmart faced when the suit was filed in December 2020. Federal prosecutors alleged that some compliance staff were aware certain prescribers operated "pill mills."

Opioids such as oxycodone and hydrocodone are used for pain treatment but have contributed to widespread addiction and overdose deaths in the U.S.

Financial Performance

Walmart reported strong financial results alongside the settlement news. For the six months ended July 31, the company posted $11.79 billion in net income.

In its second-quarter results released last week, Walmart reported revenue of $187.94 billion, slightly above the expected $186.71 billion. Adjusted earnings per share came in at $0.81, beating the analyst estimate of $0.74 by 9.46%.

What the Numbers Show

The $50 million settlement represents approximately 0.42% of Walmart’s reported Q2 revenue of $187.94 billion. This scale supports management’s characterization of the payout as immaterial relative to the company’s current operating scale.

Industry Landscape

Federal and state authorities have pursued opioid-related cases across the supply chain. Manufacturers like Purdue Pharma and distributors such as Cencora Inc. (NYSE: COR) have faced similar scrutiny. Retail pharmacy operators including CVS Health Corp. (NYSE: CVS) and Walgreens have reached larger settlements.

According to the Centers for Disease Control and Prevention, approximately 806,000 people died from opioid-involved overdoses between 1999 and 2023. Including provisional estimates for 2025, the cumulative total reaches approximately 905,000 deaths.

Trading Metrics

Walmart has a market capitalization of $820.4 billion. The stock closed at $103.09 on Friday, up 0.45%. Over the past 12 months, the stock has risen 7.26% but is down 8.58% year to date.

Walmart Inc (NYSE: WMT) shares declined 1.42% to $102.86 on Thursday as investors reacted to slower-than-expected U.S. comparable-store sales growth in its second-quarter fiscal 2027 results.

The retailer reported total revenue of $187.94 billion, up 5.9% year-over-year, and adjusted earnings per share (EPS) of 81 cents, both beating consensus Wall Street estimates. Management also raised its full-year fiscal 2027 net sales growth guidance to 4.0%–5.0% and adjusted EPS expectations to $2.80–$2.87.

Earnings Beat Overshadowed by Slowest U.S. Comp Growth in 6 Years

Investor enthusiasm was dampened by U.S. comparable-store sales growth of just 2.6% (excluding fuel). This figure missed Wall Street’s 3.8% projection and marked the retailer’s slowest comp-sales pace in nearly six years.

The decelerating store metrics sparked concerns over persistent inflation headwinds, weaker consumer discretionary spending, and market share pressure from rival Amazon in core categories like apparel.

Management Focuses on High-Margin Flywheel and Price Rollbacks

During the second-quarter earnings call on August 20, CEO John Furner addressed consumer behavior and the strategic push to maintain price leadership through permanent rollbacks.

"Price investments are carefully managed for maximum return and are intended to become permanent where delivering share gains... We continue to track rollbacks for unit and share gains, with permanence determined by performance metrics," Furner said.

CFO John David Rainey highlighted the rapid expansion of non-retail, high-margin platforms, noting that profit growth is increasingly driven by these businesses rather than traditional retail units.

"While unit growth is immediate, the full sales impact accumulates over time as rollbacks gain traction," Rainey stated.

What the Numbers Show

The divergence between the overall revenue beat and the specific miss in U.S. comp-sales suggests that Walmart’s top-line growth is being supported by non-U.S. operations or high-margin platform businesses, rather than organic traffic growth in its core U.S. stores. While total revenue grew 5.9%, the underlying U.S. store momentum slowed to a six-year low of 2.6%, indicating a shift in profit drivers toward digital and platform services as physical retail faces margin pressures.